BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,197,000 | -36.4% | 3,287,000 | -35.6% | 0.00% | -33.3% |
| Q2 2023 | $5,024,695 | +19.1% | 5,107,000 | +24.3% | 0.01% | +20.0% |
| Q1 2023 | $4,217,427 | -10.7% | 4,107,000 | -7.5% | 0.01% | 0.0% |
| Q4 2022 | $4,724,000 | +81.3% | 4,442,000 | +69.4% | 0.01% | +66.7% |
| Q3 2022 | $2,605,000 | -43.7% | 2,622,000 | -43.8% | 0.00% | -50.0% |
| Q2 2022 | $4,625,000 | -1.2% | 4,667,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $4,682,000 | -25.4% | 4,667,000 | -22.0% | 0.00% | -20.0% |
| Q4 2021 | $6,280,000 | -1.7% | 5,982,000 | -3.5% | 0.01% | 0.0% |
| Q3 2021 | $6,388,000 | -13.2% | 6,199,000 | -12.4% | 0.01% | -16.7% |
| Q2 2021 | $7,361,000 | +0.5% | 7,078,000 | -1.5% | 0.01% | -40.0% |
| Q1 2021 | $7,326,000 | +1.0% | 7,188,000 | +6.4% | 0.01% | -9.1% |
| Q4 2020 | $7,256,000 | -14.5% | 6,753,000 | -16.3% | 0.01% | -21.4% |
| Q3 2020 | $8,484,000 | -37.7% | 8,067,000 | -27.3% | 0.01% | -39.1% |
| Q2 2020 | $13,609,000 | +58.6% | 11,101,000 | +35.6% | 0.02% | +27.8% |
| Q1 2020 | $8,583,000 | +42.3% | 8,187,000 | -8.2% | 0.02% | +100.0% |
| Q4 2019 | $6,032,000 | +89.6% | 8,915,000 | +176.9% | 0.01% | +80.0% |
| Q3 2019 | $3,181,000 | +318000.0% | 3,220,000 | -57.9% | 0.01% | – |
| Q2 2019 | $1,000 | 0.0% | 7,650,000 | +200.0% | 0.00% | – |
| Q1 2019 | $1,000 | -100.0% | 2,550,000 | -15.0% | 0.00% | -100.0% |
| Q4 2018 | $2,986,000 | -6.1% | 3,000,000 | 0.0% | 0.01% | +20.0% |
| Q3 2018 | $3,179,000 | +4.2% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $3,050,000 | +8.1% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $2,822,000 | -5.9% | 3,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $2,999,000 | +47.7% | 3,000,000 | +50.0% | 0.01% | +25.0% |
| Q3 2017 | $2,031,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |